LBNL Logo ONHS Funding Opportunity Report

DoW Breast Cancer, Breakthrough Award Levels 1 and 2

Solicitation ID: HT942526BCRPBTA122

Agency: Department of Defense/BCRP

Type: Grant
Deadline: 2026-11-18T00:00:00 ET
Eligibility: Maybe (Unspecified)
Funding: N/A
Doc Type: BAA
Clearance: No
Program Manager: N/A
Last Updated: 2026-08-20 16:02
Analyzed File: API_Description.txt

Eligibility Reasoning

Eligibility for FFRDCs or National Labs was not mentioned.

Note: This is an AI-generated summary...

Summary

[Analyzed from API Fallback] The Fiscal Year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award supports high-impact research for breakthroughs in breast cancer. This specific announcement covers Level 1 and Level 2 funding. Level 2 offers a Population Science Studies option, which may allow for higher funding and an extended period of performance. Applications must address an FY26 BCRP overarching challenge and can be submitted by a single Principal Investigator (PI) or through a Partnering PI Option (PPIO) with two PIs.

Overall Technical Areas

Breast Cancer BiologyCancer Genetics and GenomicsTumor Microenvironment ResearchCancer ImmunologyTherapeutic DevelopmentTreatment Resistance MechanismsBiomarker Discovery and ValidationTranslational Cancer ResearchPopulation Science StudiesCancer EpidemiologyHealth Disparities ResearchComputational Biology and BioinformaticsClinical Research DesignAdvanced Cancer Imaging

Probable LBNL Areas

N/A

Focus Areas

N/A

Potential LBNL PIs (Overall)

Note on PI Matching: These suggestions are generated through an AI-driven semantic analysis of LBNL staff profiles.

NameScoreOrganization
Jennifer Rosenbluth0.79 · Breast Cancer Biology
Georgios Pavlopoulos0.77BSA | DOE Joint Genome Institute | JGI Science Dept · Computational Biology and Bioinformatics
Jinyi Qi0.76BSA | Molecular Biophysics & Integrated Bioimaging | Cellular & Tissue Image · Advanced Cancer Imaging
James Garbe0.76BSA | Biological Systems & Engineering | Department of BioEngineering and BioMedical Sciences · Cancer Epidemiology
Jian-Hua Mao0.75BSA | Biological Systems & Engineering | Department of BioEngineering and BioMedical Sciences · Cancer Genetics and Genomics
Javier Caravaca Rodriguez0.74PSA | NSD | ANP · Therapeutic Development
Chris Mungall0.73BSA | Env. Genomics & Sys. Biology | BioSystems Data Science · Clinical Research Design
Justin Reese0.73BSA | Env. Genomics & Sys. Biology | BioSystems Data Science · Health Disparities Research
Sharon Greenblum0.73BSA | DOE Joint Genome Institute | JGI Technology Dept · Treatment Resistance Mechanisms
Yun Song0.72CSA | AMCR | Computer Science · Population Science Studies

Fundamental Research Exemption (FRE)

Not Mentioned